Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY) : a randomised, controlled, open-label, platform trial
| dc.contributor.author | RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Education | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Cardiometabolic Disease | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.date.accessioned | 2025-10-23T10:12:01Z | |
| dc.date.issued | 2023-05-06 | |
| dc.description | We thank the thousands of patients who participated in this trial and the many doctors, nurses, pharmacists, and other allied health professionals. We would also like to thank research administrators at participating hospital organisations supported in the UK by staff at the National Institute of Health and Care Research (NIHR) Clinical Research Network, NHS DigiTrials, Public Health England, Department of Health and Social Care, the Intensive Care National Audit and Research Centre, Public Health Scotland, National Records Service of Scotland, the Secure Anonymised Information Linkage (SAIL) at University of Swansea, and the National Health Service in England, Scotland, Wales, and Northern Ireland. The writing committee and trial steering committee are listed at the end of this manuscript and a complete list of collaborators in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial is provided in the appendix (pp 2–31) | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 1090365 | |
| dc.identifier | 306076734 | |
| dc.identifier | 6c695eec-a1cc-410f-89d1-6223d64a05a9 | |
| dc.identifier | 37060915 | |
| dc.identifier | 85153865218 | |
| dc.identifier.citation | RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk 2023, 'Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY) : a randomised, controlled, open-label, platform trial', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507. https://doi.org/10.1016/S0140-6736(23)00510-X | en |
| dc.identifier.doi | 10.1016/S0140-6736(23)00510-X | |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.other | PubMedCentral: PMC10156147 | |
| dc.identifier.other | ORCID: /0000-0003-3812-7026/work/195319971 | |
| dc.identifier.other | ORCID: /0000-0003-2115-8184/work/198455223 | |
| dc.identifier.other | ORCID: /0000-0002-1397-4272/work/198456673 | |
| dc.identifier.other | ORCID: /0000-0002-6904-7048/work/198457001 | |
| dc.identifier.other | ORCID: /0000-0003-3989-514X/work/198458548 | |
| dc.identifier.uri | https://hdl.handle.net/2164/26273 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Lancet (London, England) | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Adult | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Female | en |
| dc.subject | COVID-19 | en |
| dc.subject | SARS-CoV-2 | en |
| dc.subject | Hospitals | en |
| dc.subject | Oxygen | en |
| dc.subject | Hypoxia/etiology | en |
| dc.subject | Adrenal Cortex Hormones/therapeutic use | en |
| dc.subject | Dexamethasone/therapeutic use | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R1 | en |
| dc.title | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY) : a randomised, controlled, open-label, platform trial | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Recovery_TL_Higher_Dose_Corticosteroids_VOR.pdf
- Size:
- 1.04 MB
- Format:
- Adobe Portable Document Format